Skip to main content
Top
Published in: Rheumatology International 6/2010

01-04-2010 | Original Article

Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1

Authors: Ana Karina Ferraz-Chaoui, Ajax Mercês Atta, Maria Luiza Sousa Atta, Bernardo Galvão-Castro, Mittermayer B. Santiago

Published in: Rheumatology International | Issue 6/2010

Login to get access

Abstract

Human T cell lymphotropic virus type 1 (HTLV-1) is endemic in many regions of the world, including Brazil, and has been associated to several immunological manifestations such as arthritis, uveitis, dermatitis and Sjögren’s syndrome. This study was intended to evaluate the frequency of autoantibodies in patients infected with HTLV-1 and manifesting keratoconjunctivitis sicca (KCS). HTLV-1 patients with KCS, enrolled in a reference ambulatory of the city of Salvador, were tested for autoantibodies such as antinuclear antibodies, rheumatoid factor, anti-SSA/Ro and anti-SSB/La. Two comparison groups were also included: (a) HTLV-1 patients without KCS and (b) seronegative patients with KCS. Correlation of proviral load (PVL) in HTLV-1 patients with presence or absence of KCS was also assessed. No autoantibodies were detected in HTLV-1 patients with KCS. The PVL of HTLV-1 patients was higher in patients with KCS without other clinical manifestations customarily associated to HTLV-1. In conclusion, in this study, no changes were observed in humoral immunity concerning production of certain autoantibodies in HTLV-1-infected patients with KCS, which suggests that other mechanisms may be involved in the pathogenesis of this manifestation. Additionally, PVL may be a marker of KCS development in these patients.
Literature
1.
go back to reference Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415–7419CrossRefPubMed Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77(12):7415–7419CrossRefPubMed
2.
go back to reference Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068CrossRefPubMed Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058–6068CrossRefPubMed
3.
go back to reference Galvao-Castro B, Loures L, Rodriques LG et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242–243CrossRefPubMed Galvao-Castro B, Loures L, Rodriques LG et al (1997) Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37(2):242–243CrossRefPubMed
4.
go back to reference Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B (2003) HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 34(5):527–531CrossRefPubMed Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvao-Castro B (2003) HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 34(5):527–531CrossRefPubMed
5.
go back to reference Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031–2035CrossRefPubMed Yoshida M, Miyoshi I, Hinuma Y (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci USA 79(6):2031–2035CrossRefPubMed
6.
go back to reference Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410CrossRefPubMed Gessain A, Barin F, Vernant JC et al (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2(8452):407–410CrossRefPubMed
7.
go back to reference Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1(8635):441CrossRefPubMed Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M (1989) Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1(8635):441CrossRefPubMed
8.
go back to reference Ijichi S, Matsuda T, Maruyama I, Ijichi S et al (1990) Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49(9):718–721CrossRefPubMed Ijichi S, Matsuda T, Maruyama I, Ijichi S et al (1990) Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier. Ann Rheum Dis 49(9):718–721CrossRefPubMed
9.
go back to reference Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2(8673):1184–1187CrossRefPubMed Morgan OS, Rodgers-Johnson P, Mora C, Char G (1989) HTLV-1 and polymyositis in Jamaica. Lancet 2(8673):1184–1187CrossRefPubMed
10.
go back to reference Eguchi K, Matsuoka N, Ida H et al (1992) Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51(6):769–776CrossRefPubMed Eguchi K, Matsuoka N, Ida H et al (1992) Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis 51(6):769–776CrossRefPubMed
11.
go back to reference Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet 344(8930):1116–1119CrossRefPubMed Terada K, Katamine S, Eguchi K et al (1994) Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet 344(8930):1116–1119CrossRefPubMed
12.
go back to reference Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83(3):236–239PubMed Mochizuki M, Watanabe T, Yamaguchi K et al (1992) HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 83(3):236–239PubMed
13.
go back to reference Merle H, Cabre P, Merle S, Gerard M, Smadja D (2001) A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol 131(3):305–308CrossRefPubMed Merle H, Cabre P, Merle S, Gerard M, Smadja D (2001) A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol 131(3):305–308CrossRefPubMed
14.
go back to reference Buggage RR, Levy-Clarke GA, Smith JA (2001) New corneal findings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol 131(3):309–313CrossRefPubMed Buggage RR, Levy-Clarke GA, Smith JA (2001) New corneal findings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol 131(3):309–313CrossRefPubMed
15.
go back to reference Merle H, Smadja D, Le Hoang P, Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-I associated infection–a clinical study of 93 cases. Jpn J Ophthalmol 40(2):260–270PubMed Merle H, Smadja D, Le Hoang P, Merle H, Smadja D, Le Hoang P et al (1996) Ocular manifestations in patients with HTLV-I associated infection–a clinical study of 93 cases. Jpn J Ophthalmol 40(2):260–270PubMed
16.
go back to reference Merle H, Cabre P, Olindo S, Merle S, Smadja D (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134(2):190–195CrossRefPubMed Merle H, Cabre P, Olindo S, Merle S, Smadja D (2002) Ocular lesions in 200 patients infected by the human T-cell lymphotropic virus type 1 in martinique (French West Indies). Am J Ophthalmol 134(2):190–195CrossRefPubMed
17.
go back to reference Nakamura H, Eguchi K, Nakamura T et al (1997) High prevalence of Sjogren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56(3):167–172CrossRefPubMed Nakamura H, Eguchi K, Nakamura T et al (1997) High prevalence of Sjogren’s syndrome in patients with HTLV-I associated myelopathy. Ann Rheum Dis 56(3):167–172CrossRefPubMed
18.
go back to reference Vitali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55(2):116–121CrossRefPubMed Vitali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classification criteria for Sjogren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjogren’s syndrome. Ann Rheum Dis 55(2):116–121CrossRefPubMed
19.
go back to reference Dehee A, Cesaire R, Desire N et al (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1–2):37–51CrossRefPubMed Dehee A, Cesaire R, Desire N et al (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 102(1–2):37–51CrossRefPubMed
20.
go back to reference Green JE, Hinrichs SH, Vogel J, Jay G (1989) Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice. Nature 341(6237):72–74CrossRefPubMed Green JE, Hinrichs SH, Vogel J, Jay G (1989) Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice. Nature 341(6237):72–74CrossRefPubMed
21.
go back to reference Hida A, Kawabe Y, Kawakami A et al (1999) HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome. Ann Rheum Dis 58(5):320–322CrossRefPubMed Hida A, Kawabe Y, Kawakami A et al (1999) HTLV-I associated Sjogren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjogren’s syndrome. Ann Rheum Dis 58(5):320–322CrossRefPubMed
22.
go back to reference Nakamura H, Kawakami A, Tominaga M et al (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 135(2):139–144CrossRefPubMed Nakamura H, Kawakami A, Tominaga M et al (2000) Relationship between Sjogren’s syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med 135(2):139–144CrossRefPubMed
23.
go back to reference Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol 21(5):656–660CrossRefPubMed Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjogren’s disease. J Clin Pathol 21(5):656–660CrossRefPubMed
24.
go back to reference Merle H, Cabre P, Smadja D, Josset P, Landau M, Vernant JC (1999) Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis. Jpn J Ophthalmol 43(6):509–512CrossRefPubMed Merle H, Cabre P, Smadja D, Josset P, Landau M, Vernant JC (1999) Sicca syndrome and HTLV-I-associated myelopathy/tropical spastic paraparesis. Jpn J Ophthalmol 43(6):509–512CrossRefPubMed
25.
go back to reference Pinheiro SR, Lana-Peixoto MA, Proietti AB et al (1995) HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren’s syndrome. Arq Neuropsiquiatr 53(4):777–781PubMed Pinheiro SR, Lana-Peixoto MA, Proietti AB et al (1995) HTLV-I associated uveitis, myelopathy, rheumatoid arthritis and Sjogren’s syndrome. Arq Neuropsiquiatr 53(4):777–781PubMed
26.
go back to reference Moraes HV Jr, Branco RL, Pinto CMS, Dantas MM, Fiszman R (1995) HTLV-I e Uveíte. Revista Brasileira de Oftalmologia 54(12):39–42 Moraes HV Jr, Branco RL, Pinto CMS, Dantas MM, Fiszman R (1995) HTLV-I e Uveíte. Revista Brasileira de Oftalmologia 54(12):39–42
27.
go back to reference Pinheiro SR, Martins-Filho AO, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142(5):811–815CrossRefPubMed Pinheiro SR, Martins-Filho AO, Ribas JG et al (2006) Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol 142(5):811–815CrossRefPubMed
28.
go back to reference Giozza SP, Santos SB, Martinelli M, Porto MA, Muniz AL, Carvalho EM (2008) Salivary and lacrymal gland disorders and HTLV-1 infection. Rev Stomatol Chir Maxillofac 109(3):153–157CrossRefPubMed Giozza SP, Santos SB, Martinelli M, Porto MA, Muniz AL, Carvalho EM (2008) Salivary and lacrymal gland disorders and HTLV-1 infection. Rev Stomatol Chir Maxillofac 109(3):153–157CrossRefPubMed
29.
go back to reference Santiago M, Crusoé EQ, Matos AV (2002) Manifestações reumatológicas associadas à infecção pelo HTLV-I. Rev Bras Reumatol 42(5):306–310 Santiago M, Crusoé EQ, Matos AV (2002) Manifestações reumatológicas associadas à infecção pelo HTLV-I. Rev Bras Reumatol 42(5):306–310
30.
go back to reference Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T (1995) Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 79(3):270–276CrossRefPubMed Ono A, Mochizuki M, Yamaguchi K, Miyata N, Watanabe T (1995) Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol 79(3):270–276CrossRefPubMed
31.
go back to reference Best I, Adaui V, Verdonck K et al (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol 146(2):226–233CrossRefPubMed Best I, Adaui V, Verdonck K et al (2006) Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru. Clin Exp Immunol 146(2):226–233CrossRefPubMed
32.
go back to reference Montanheiro PA, Oliveira AC, Posada-Vergara MP et al (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 38(11):1643–1647CrossRefPubMed Montanheiro PA, Oliveira AC, Posada-Vergara MP et al (2005) Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Braz J Med Biol Res 38(11):1643–1647CrossRefPubMed
Metadata
Title
Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1
Authors
Ana Karina Ferraz-Chaoui
Ajax Mercês Atta
Maria Luiza Sousa Atta
Bernardo Galvão-Castro
Mittermayer B. Santiago
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2010
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1066-5

Other articles of this Issue 6/2010

Rheumatology International 6/2010 Go to the issue